WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
98.01
0.00 (0.00%)
At close: Feb 27, 2026
52.12%
Market Cap 293.70B
Revenue (ttm) 43.88B
Net Income (ttm) 14.99B
Shares Out 2.96B
EPS (ttm) 4.65
PE Ratio 19.39
Forward PE 15.77
Dividend 0.70 (0.71%)
Ex-Dividend Date Sep 26, 2025
Volume 23,505,880
Average Volume 36,055,020
Open 97.88
Previous Close 98.01
Day's Range 97.18 - 99.08
52-Week Range 48.48 - 115.79
Beta 0.62
RSI 48.78
Earnings Date Mar 24, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Sector Healthcare
Founded 2000
Employees 37,832
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial Statements

News

There is no news available yet.